01 December 2008
Acute short-term hyperglycemia impairs platelet receptor expression even in healthy adults in vitro
Tobias SchuerholzACDEF, Wolfgang LöscheCDEF, Oliver KeilABDF, Lars FriedrichABE, Tim-Phillip SimonDEF, Gernot MarxADEGMed Sci Monit 2008; 14(12): BR294-298 :: ID: 869478
Abstract
Background
Platelet function is crucial in intensive care patients. Several factors like hyperglycemia may influence this function. Recently, it was demonstrated that the prevention of hyperglycemia could reduce mortality even in non-diabetic individuals. The aim of the present study was to examine effects of an acute hyperglycemia on platelet receptor expression in non-diabetic healthy individuals in vitro.
Material and Method
Citrated blood samples were drawn from twenty-five healthy blood donors and adjusted to final concentrations of 10 mmol l(-1) and 15 mmol l(-1) glucose, respectively. The control group with blood glucose of 5 mmol l(-1) received no additional glucose. Expression of CD62P, CD41, CD36, and CD42b on the surface of resting or agonist-stimulated platelets was determined by whole blood flow cytometry using fluorescence-labeled monoclonal antibodies. Platelet aggregation in platelet rich plasma was induced with ADP and collagen and recorded using a turbidimetric coagulation analyzer.
Results
Hyperglycemia had no significant influence on the expression of CD62P and CD36. At glucose concentration of 15 mmoles l(-1) the expression of both CD42b and CD41 was decreased in resting platelets a well as in platelets stimulated with 5 microM ADP or 6 microM TRAP-6. The addition of 10 mmoles l(-1) glucose caused a significant inhibition of CD41 expression in ADP-stimulated samples. The results of platelet aggregation showed no significant differences between the groups.
Conclusions
Short term hyperglycemia up to 15 mmoles l(-1) may decrease the expression of CD41 and CD42b, but not that of CD62P and CD36 on platelets in healthy adults. However functional abilities tested by aggregation are not affected.
Keywords: Hyperglycemia - blood, Platelet Membrane Glycoproteins - metabolism, Antigens, CD - blood
668 1
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952